This Industry Focus eBook on Neurology and Neuroscience brings together expert perspectives on Alzheimer’s disease and the broader field of brain health.
As progress in diagnostics, therapeutics, biomarker development, and digital health continues, our understanding of Alzheimer’s disease and related neurological conditions is becoming more refined. Work taking place across research laboratories and clinical settings is informing earlier detection strategies, more precise measurement tools, and evolving approaches to patient care.
Inside this eBook, you’ll find coverage of key developments across the field, from advances in blood-based biomarkers and metabolic research to the use of artificial intelligence in neurological imaging and luminescence immunoassays designed to improve the detection of tau pathology. It also examines how factors such as the gut microbiome and sex-specific risk profiles are influencing prevention strategies and long-term care planning.
Technology remains central throughout, with insights into how machine learning and sensor-based systems are supporting earlier intervention and more responsive care environments for individuals living with Alzheimer’s and related disorders.
Download the eBook to explore the research, perspectives, and practical insights shaping the future of neurology and neuroscience.
About IBL International GmbH, Part of Tecan Group
Specialty diagnostics to improve people’s lives and health
With decades of experience, Tecan has built a strong legacy of innovation in in vitro diagnostic testing for endocrinology, immunology and autoimmunity at IBL International, specializing in the development, manufacture and supply of immunoassays as well as LC-MS solutions. These products are designed and produced to the highest standards, providing diagnostics labs with reliable data and improved workflow efficiency to assess various health conditions from blood, urine, saliva and cerebrospinal fluid samples.
Tecan’s reagents portfolio includes a number of specialty diagnostic assays for endocrinology, immunology, neurotransmitters and autoimmunity in clinical diagnostics, along with key assays for the research segment, including BD-Tau LUM and NF Light®* ELISA.
By combining Tecan’s proven automation capabilities and leadership in instrumentation with IBL International’s specialized immunoassay and LC-MS portfolio, Tecan offers complete solutions tailored to the needs of specialty diagnostics and research laboratories. These offerings streamline lab workflows by boosting productivity, increasing efficiency and meeting high regulatory standards.
This focus on compliance helped Tecan respond quickly to the EU’s In Vitro Diagnostic Regulation (IVDR), becoming one of the first companies to achieve product certification under the new rules.
Tecan continues to invest in innovation, advancing its portfolio to address emerging diagnostic needs in both clinical and research settings. Recent developments include specialized assays such as BD-Tau, sIL-2R, SCCA2 and Periostin ELISAs, supporting neurology and immunology applications, as well as LC-MS based assays for vitamins B1 and B6, A and E testing in endocrinology.
Disclaimer:
Products manufactured and distributed by IBL International. Availability and regulatory status may vary across regions depending on local country specific registration. The combined use of the reagents, process script and instrument has to be validated individually on site by each laboratory.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.